Zydis selegiline in the management of Parkinson's disease.

about

Non-oral dopaminergic therapies for Parkinson's disease: current treatments and the future Orally disintegrating dosage forms and taste-masking technologies; 2010.Allergy immunotherapy tablet: Grazax®for the treatment of grass pollen allergy

P2860

Q33917283-A89EC8B4-845B-4615-9FA6-33DF5E1A204F Q37857859-CDE4A09D-3F20-40D6-8474-D8CCA3C037FB Q58823379-67793DE9-77AC-49D3-91B1-3AE7D7D2F09F

P2860

Zydis selegiline in the management of Parkinson's disease.

Item

http://www.wikidata.org/entity/Q36968199

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Zydis selegiline in the management of Parkinson's disease.

@en

type

Item

label

Zydis selegiline in the management of Parkinson's disease.

@en

prefLabel

Zydis selegiline in the management of Parkinson's disease.

@en

P1476

Zydis selegiline in the management of Parkinson's disease.

@en

P2093

Cheryl Waters

http://www.w3.org/2001/XMLSchema#string

Kathleen L Poston

http://www.w3.org/2001/XMLSchema#string

P2860

Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine

Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline

Rasagiline: a review of its use in the management of Parkinson's disease

Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease

Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity

Stages in the development of Parkinson's disease-related pathology

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson'

Epidemiology of Parkinson's disease and akinetic syndromes.

Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.

Neuroprotective actions of selegiline.

P304

2615-2624

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.8.15.2615

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17931095

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

Zydis selegiline in the management of Parkinson's disease.

about

P2860

P2860

Zydis selegiline in the management of Parkinson's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921